Kotra Industries Berhad (KLSE:KOTRA)

Theseus Pharmaceuticals Balance Sheet

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	17.55	5.41	7.35	23.27	7.55	7.33
Short-Term Investments	21.86	60.87	81.95	66.75	61.5	42.41
Cash & Short-Term Investments	39.41	66.28	89.3	90.02	69.05	49.74
Cash Growth	-34.55%	-25.77%	-0.80%	30.37%	38.82%	70.48%
Accounts Receivable	36.96	36.11	34.56	35.12	22.62	25.16
Other Receivables	2.33	0.4	0.34	0.62	0.23	0.11
Receivables	39.29	36.51	34.9	35.74	22.85	25.28
Inventory	51.55	54.64	59.2	45.7	34.3	39.04
Prepaid Expenses	-	0.2	0.16	1.12	0.18	0.25
Other Current Assets	-	1.84	1.62	8.06	1.67	1.19
Total Current Assets	130.25	159.48	185.18	180.64	128.06	115.49
Property, Plant & Equipment	198.1	178.23	137	110.21	120.17	131.55
Long-Term Deferred Tax Assets	-	-	6.79	6.97	2.96	4.8
Other Long-Term Assets	1.27	1.29	1.31	1.34	1.36	1.39
Total Assets	329.62	338.99	330.28	299.15	252.54	253.23
Accounts Payable	15.91	18.25	20.55	18.55	14.71	17.9
Accrued Expenses	-	8.45	11.09	8.96	7.13	7.88
Current Portion of Long-Term Debt	-	-	-	6.67	11.23	13.18
Current Portion of Leases	0.24	0.96	0.96	0.97	0.97	1.01
Current Income Taxes Payable	2.37	1.64	0.22	-	-	0
Other Current Liabilities	35.34	31.75	25.48	18.66	3.92	3.6
Total Current Liabilities	53.86	61.04	58.3	53.81	37.96	43.57
Long-Term Debt	-	-	-	-	6.67	18.03
Long-Term Leases	0.08	0.08	0.08	0.08	0.08	0.08
Long-Term Unearned Revenue	0.36	0.55	0.82	1.12	1.41	1.71
Other Long-Term Liabilities	5.07	1.88	-	-	-	-
Total Liabilities	59.36	63.55	59.2	55.01	46.12	63.39
Common Stock	86.28	86.28	84.9	84.77	84.72	81.82
Retained Earnings	183.98	189.16	186.03	159.28	121.6	106.82
Comprehensive Income & Other	-	-	0.15	0.1	0.11	1.2
Shareholders' Equity	270.26	275.44	271.08	244.14	206.42	189.85
Total Liabilities & Equity	329.62	338.99	330.28	299.15	252.54	253.23
Total Debt	0.33	1.04	1.05	7.72	18.96	32.3
Net Cash (Debt)	39.08	65.24	88.26	82.3	50.09	17.44
Net Cash Growth	-34.73%	-26.08%	7.24%	64.29%	187.25%	-
Net Cash Per Share	0.26	0.44	0.60	0.56	0.34	0.12
Filing Date Shares Outstanding	148.31	148.31	148.31	147.99	147.97	147.63
Total Common Shares Outstanding	148.31	148.31	148.06	147.97	147.94	145.47
Working Capital	76.39	98.43	126.88	126.82	90.1	71.93
Book Value Per Share	1.82	1.86	1.83	1.65	1.40	1.31
Tangible Book Value	270.26	275.44	271.08	244.14	206.42	189.85
Tangible Book Value Per Share	1.82	1.86	1.83	1.65	1.40	1.31
Buildings	-	58.88	58.78	58.78	58.73	58.73
Machinery	-	200.47	198.19	196.68	193.74	191.07
Construction In Progress	-	91.46	39.47	1.65	0.42	0.37

Source: S&P Global Market Intelligence. Standard template. Financial Sources.